arznei-telegramm® 11/2016 |
SPOT ON |
How to manage muscular symptoms in patients on statins? |
NEW ON THE MARKET |
Opicapone (ONGENTYS) for PARKINSON's disease |
a-t READER'S QUESTIONS AND COMMENTS |
Increased mortality following inactivated vaccines? |
IN BRIEF |
Who benefits from long-term oxygen in chronic obstructive pulmonary disease? |
Overweight, diabetes and the soft drink industry | Hydroxyethyl starch (HES; e.g. VOLUVEN) - requested trials have not even started |
China - 80% of clinical trials with fraudulent or deficient data |
CURRENT ADR NETWORK REPORT |
Hypersensitivity reactions to SINUPRET preparations |
SIDE EFFECTS |
Pulmonary hypertension with sofosbuvir (SOVALDI, in HARVONI, EPCLUSA) |
Suicidality with the antipsoriatic drug apremilast (OTEZLA) |
Brimonidine (MIRVASO) for rosacea: often worse than better |